Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies
Lidia Sarro(Fondazione IRCCS Istituto Neurologico Carlo Besta), Kejal Kantarci(Mayo Clinic in Arizona), Clifford R. Jack(Mayo Clinic), Jonathan Graff‐Radford(Mayo Clinic), Scott A. Przybelski(Mayo Clinic in Florida), Tanis J. Ferman(Jacksonville College), Val J. Lowe(Mayo Clinic), Ronald C. Petersen(Mayo Clinic in Arizona), Matthew L. Senjem(Mayo Clinic in Florida), Timothy G. Lesnick(Mayo Clinic in Florida), David S. Knopman(Mayo Clinic), Bradley F. Boeve(Mayo Clinic in Arizona), Emily S. Lundt(Mayo Clinic in Florida), Gıancarlo Comı(Casa di Cura Columbus), Massimo Filippi(Vita-Salute San Raffaele University)
Cited by 87
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k